Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Matthew H. Nieder is active.

Publication


Featured researches published by Matthew H. Nieder.


Archive | 1999

Prodrug compounds and process for preparation thereof

Thomas J. Lobl; Vincent Dubois; Anne-Marie Fernandez; Sanjeev Gangwar; Evan Lewis; Matthew H. Nieder; Andre Trouet; Peter Viski; Geoffrey T. Yarranton


Cancer Research | 2002

CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity.

Vincent Dubois; Luc Dasnois; Karim Lebtahi; Françoise Collot; Nathalie Heylen; Nathalie Havaux; Anne-Marie Fernandez; Thomas J. Lobl; Cecilia Oliyai; Matthew H. Nieder; Dan Shochat; Geoffrey T. Yarranton; André Trouet


Cancer Research | 2003

CD10 Is a Key Enzyme Involved in the Activation of Tumor-activated Peptide Prodrug CPI-0004Na and Novel Analogues: Implications for the Design of Novel Peptide Prodrugs for the Therapy of CD10+ Tumors

Chin Pan; Pina M. Cardarelli; Matthew H. Nieder; Lesley B. Pickford; Sanjeev Gangwar; David John King; Geoffrey T. Yarranton; Dana Buckman; William Roscoe; Fengmin Zhou; Adam Salles; Tseng-Hui Chen; Killian Horgan; Yi-Hong Wang; Thi hien Nguyen; Christopher Bebbington


Archive | 2001

Prodrug compounds cleavable by thimet oligopeptidase

Matthew H. Nieder; Vincent Dubois; Sanjeev Gangwar; Thomas J. Lobl; Lesley B. Pickford; Andre Trouet; Geoffrey T. Yarranton


European Journal of Cancer | 2006

Thimet oligopeptidase (EC 3.4.24.15) activates CPI-0004Na, an extracellularly tumour-activated prodrug of doxorubicin.

Vincent Dubois; Matthew H. Nieder; F Collot; A Negrouk; T T Nguyen; S Gangwar; B Reitz; R. Wattiez; Luc Dasnois; André Trouet


Archive | 2001

Prodrug compounds with an oligopeptide having an isoleucine residue

Lesley B. Pickford; Sanjeev Gangwar; Thomas J. Lobl; Matthew H. Nieder; Geoffrey T. Yarranton


Archive | 2002

Methode für die ausarbeitung von cd10-aktivierten prodrug-verbindungen Method for the elaboration of CD10-activated prodrug compounds

Christopher R. Bebbington; Matthew H. Nieder; Pina M. Cardarelli; Sanjeev Gangwar; Lesley B. Pickford; Chin Pan


Archive | 2002

Composes pour promedicaments actives cd10

Christopher R. Bebbington; Matthew H. Nieder; Pina M. Cardarelli; Sanjeev Gangwar; Lesley B. Pickford; Chin Pan


Archive | 2002

METHODE FÜR DIE AUSARBEITUNG VON CD10-AKTIVIERTEN PRODRUG-VERBINDUNGEN

Christopher R. Bebbington; Matthew H. Nieder; Pina M. Cardarelli; Sanjeev Gangwar; Lesley B. Pickford; Chin Pan


Archive | 2001

Composes de promedicament a clivage enzymatique

Matthew H. Nieder; Vincent Dubois; Sanjeev Gangwar; Thomas J. Lobl; Lesley B. Pickford; Andre Trouet; Geoffrey T. Yarranton

Collaboration


Dive into the Matthew H. Nieder's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Vincent Dubois

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andre Trouet

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Anne-Marie Fernandez

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Chin Pan

Bristol-Myers Squibb

View shared research outputs
Researchain Logo
Decentralizing Knowledge